Role of p38 mitogen-activated protein kinase in cardiac myocyte secretion of the inflammatory cytokine TNF-α

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 280, Issue 5 49-5, 2001, Pages

  Ballard Croft, Cherry ^a   White, D Jean ^a   Maass, David L ^a   Hybki, Dixie Peters ^a   Horton, Jureta W ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Cardiac contraction relaxation; Langendorff perfusion; Rat model of burn trauma; Tumor necrosis factor

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CYTOKINE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; RINGER LACTATE SOLUTION; SYNAPTOPHYSIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BURN; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVATION; FLUID THERAPY; HEART CONTRACTION; HEART FUNCTION; HEART MUSCLE CELL; HEART MUSCLE RELAXATION; ISOLATED HEART; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

EID: 0035035237     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.2001.280.5.h1970     Document Type: Article

References (58)

1. Abraham E, Glauser MP, Butler T, Barbino J, Gelmont D, Laterre PF, Kudsk K, Ha HAB, Otto C, Tobin E, Zwingelstein C, Lesslauer W, and Leighton A. p55 Tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multi-center trial. Ro 45-2081 Study Group. JAMA 277: 1531-1538, 1997.
2. Abraham E, Wunderink R, Silverman H, Perl TM, Nasraway S, Levy H, Bone R, Wenzel RP, Balk R, Allred R, Pennington JE, and Wherry JC. Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. JAMA 273: 934-941, 1995.
3. Adams HR, Baxter CR, and Izenberg SD. Decreased contractility and compliance of the left ventricle as complications of thermal trauma. Am Heart J 108: 1477-1487, 1984.
4. Badger AM, Bradbeer JN, Votta B, Lee JC, Adams JL, and Griswold DE. Pharmacological profile of SB203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function. J Pharmacol Exp Ther 279: 1452-1461, 1996.
5. Badger AM, Cook MN, Lark MW, Newman-Tarr TM, Swift BA, Nelson AH, Barone FC, and Kumar S. SB 203580 inhibits p38 mitogen-activated protein kinase, nitric oxide production, and inducible nitric oxide synthase in bovine cartilage-derived chondrocytes. J Immunol 161: 467-473, 1998.
6. Badger AM, Olivera D, Talmadge JE, and Hanna N. Protective effect of SK&F 86002, a novel dual inhibitor of arachidonic acid metabolism, in murine models of endotoxin shock: Inhibition of tumor necrosis factor as a possible mechanism of action. Circ Shock 27: 51-61, 1989.
7. Bryant D, Becker L, Richardson J, Shelton J, Franco F, Peshock R, Thompson M, and Giroir B. Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha. Circulation 97: 1375-1381, 1998.
8. Cain BS, Harken AH, and Meldrum DR. Therapeutic strategies to reduce TNF-α mediated cardiac contractile depression following ischemia and reperfusion. J Mol Cell Cardiol 31: 931-947, 1999.
9. Cain BS, Meldrum DR, Dinarello CA, Meng X, Joo KS, Banergee A, and Harken AH. Tumor necrosis factor-α and interleukin-1β synergistically depress human myocardial function. Crit Care Med 27: 1309-1318, 1999.
10. Cain BS, Meldrum DR, Meng X, Dinarello CA, Shames BO, Banerjee A, and Harken AH. p38 MAPK inhibition decreases TNF-α production and enhances postischemic human myocardial function. J Surg Res 83: 7-12, 1999.
11. Chan EL, Haudek SB, and Murphy JT. NF-κB regulation of TNF-α mRNA expression in endotoxin stressed human coronary endothelial cells. National ACS Committee On Trauma Resident Paper Competition, Reno, Nevada. March 9, 2000.
12. Clerk A, Michael A, and Sugden PH. Stimulation of multiple mitogen-activated protein kinase sub-families by oxidative stress and phosphorylation of the small heat shock protein, HSP25/27, in neonatal ventricular myocytes. Biochem J 333: 581-589, 1998.
13. Clerk A and Sugden PH. Mitogen-activated protein kinases are activated by oxidative stress and cytokines in neonatal rat ventricular myocytes (Abstract). Biochem Soc Trans 25: 566S, 1997.
14. Clerk A and Sugden PH. The p38 MAPK inhibitor, SB203580, inhibits cardiac stress-activated protein kinases/C-jun N-terminal kinases (SAPKs/JNKs). FEBS Lett 426: 93-96, 1998.
15. Cuenda A, Royse J, Doza YN, Meier R, Cohen P, Gallagher TF, Young PR, and Lee JC. SB203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett 364: 229-233, 1995.
16. Davis RJ. Transcriptional regulation by MAP kinases. Mol Reprod Dev 42: 459-467, 1995.
17. Deitch EA and Bridges RM. Effect of stress and trauma on bacterial translocation from the gut. J Surg Res 42: 536-542, 1987.
18. Deitch EA, Winterton J, and Berg R. Thermal injury promotes bacterial translocation from the gastrointestinal tract in mice with impaired T-cell-mediated immunity. Arch Surg 121: 97-101, 1986.
19. Dinarello CA, Gelfand JA, and Wolff SM. Anticytokine strategies in the treatment of the systemic inflammatory response syndrome. JAMA 269: 1829-1835, 1993.
20. Evans TJ, Moyes D, Carpenter A, Martin R, Loetscher H, Lesslauer W, and Cohen J. Protective effect of 55- but not 75-kDa soluble tumor necrosis factor receptor-immunoglobin G fusion proteins in an animal model of gram-negative sepsis. J Exp Med 180: 2173-2179, 1994.
21. Fisher SCJ, Opal SM, Dhainaut JF, Stephens S, Zimmerman JL, Nightingale P, Harris SJ, Schein RMH, Panacep EA, Vincent JL, Foulke GE, Warren EL, Garrard C, Park G, Bodmer MW, Cohen J, Linden CV, Cross AS, and Sadoff JC. Influence of an anti-tumor necrosis factor monoclonal anti-body on cytokine levels in patients with sepsis. Crit Care Med 21: 318-327, 1993.
22. Gallager TF, Fier-Thompson SM, Garigipati RS, Sorenson ME, Smietana JM, Lee D, Bender PE, Lee JC, Laydon JT, Griswold DE, Chabot-Fletcher MD, Breton JJ, and Adams JL. 2,4,5-Triarylimidiazole inhibitors of IL-1 biosynthesis. Bioorg Med Chem 5: 1171-1176, 1995.
23. Geppert TD, Whitehurst CE, Thompson P, and Beutler KBK. Lipopolysaccharide signals activation of tumor necrosis factor biosynthesis through the Ras/Raf-1/MEK/MAPK pathway. Mol Med 1: 93-103, 1994.
24. Giroir B, Arteaga G, White J, and Horton J. Prevention of endotoxin-induced myocardial dysfunction with TNF blockade or IL-1 blockade (Abstract). Crit Care Med 24, Suppl: A144, 1996.
25. Giroir BP, Horton JW, White DJ, McIntyre KL, and Lin CQ. Inhibition of tumor necrosis factor prevents myocardial dysfunction during burn shock. Am J Physiol Heart Circ Physiol 267: H118-H124, 1994.
26. Guan Z, Buckman SY, Pentland AP, Templeton DJ, and Morrison AR. Induction of cyclooxygenase-2 by the activated MEKK1→SEK1/MKK4→p38 mitogen-activated protein kinase pathway. J Biol Chem 273: 12901-12908, 1998.
27. Hailman E, Lichenstein HS, Worfel MM, Miller DS, Johnson Da Kelley M, Busse LA, Zakowski MM, and Wright SD. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J Exp Med 179: 269-277, 1994.
28. Han J, Lee JD, Tobias PS, and Ulevitch RJ. Endotoxin induces rapid tyrosine phosphorylation in 70Z/3 cells expressing CD14. J Biol Chem 268: 25009-25014, 1993.
29. Herndon DN and Zeigler ST. Bacterial translocation after thermal injury. Crit Care Med 21: 50-54, 1993.
30. Horton JW. Bacterial translocation after burn injury: the contribution of ischemia and permeability changes. Shock 4: 286-290, 1994.
31. Horton JW. Oxygen free radicals contribute to postburn cardiac cell membrane dysfunction. J Surg Res 61: 97-102, 1996.
32. Horton J, Maass D, Haudek S, and Giroir B. The role of NF-κB in cardiac TNF-α secretion after trauma (Abstract). Proc Am Assoc Surg Trauma, 1999.
33. Horton JW, Maass D, White J, and Sanders B. Nitric oxide modulation of TNF-α induced cardiac contractile dysfunction is concentration dependent. Am J Physiol Heart Circ Physiol 278: H1955-H1965, 2000.
34. Horton JW, Maass D, White J, and Sanders B. Hypertonic saline dextran suppresses burn-related cytokine secretion by cardiomyocytes. Am J Physiol Heart Circ Physiol 280: 1591-1601, 2001.
35. Horton JW, Mileski WJ, White DJ, and Lipsky P. Monoclonal antibody to intercellular adhesion molecule-1 reduces cardiac contractile dysfunction after burn injury in rabbits. J Surg Res 64: 49-56, 1996.
36. Horton JW and White DJ. Role of xanthine oxidase and leukocytes in postburn cardiac dysfunction. J Am Coll Surg 181: 129-137, 1995.
37. Kappadia S, Lee J, Torre-Amione G, Birdsall HH, Ma TS, and Mann DL. Tumor necrosis factor-a gene and protein expression in adult feline myocardium after endotoxin administration. J Clin Invent 96: 1042-1052, 1995.
38. Keller RS, Parker JL, Adams HR, and Rubin LJ. Contractile dysfunction and inositol phosphates in ventricular myocytes isolated from endotoxemic guinea pigs (Abstract). Circ Shock 37: 29, 1992.
39. Kumar A, Thota V, Dee L, Olson J, Uretz E, and Parillo JE. Tumor necrosis factor-alpha and interleukin 1-beta are responsible for the in vitro myocardial cell depression induced by human septic shock serum. J Exp Med 183: 949-958, 1996.
40. Lavoie JN, Lambert H, Hickey E, Weber LA, and Landry J. Modulation of cellular thermoresistance and actin filament stability accompanies phosphorylation-induced changes in the oligomeric structure of heat shock protein 27. Mol Cell Biol 15: 505-516, 1995.
41. Lee JC, Badger AM, Griswold DE, Dunnington D, Truneh A, Votta B, White JR, Young PR, and Bender PE. Bicyclic imidiazoles as a novel class of cytokine biosynthesis inhibitors. Ann NY Acad Sci 696: 149-170, 1993.
42. Lee JC, Laydon JT, McDonnel PC, Gallagher TF, Kumar S, Green D, McNulty D, Blumenthal MJ, Heys JR, Landvatter SW, Strickler JE, McLaughlin MM, Siemens IR, Fisher SM, Livi GP, White JR, Adams JL, and Young PR. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372: 739-745, 1994.
43. Maulik N, Sato M, Price BD, and Das DK. An essential role of NF-κB in tyrosine kinase signaling of p38 MAP kinase regulation of myocardial adaptation to ischemia. FEBS Lett 429: 365-369, 1998.
44. Meldrum DR. Tumor necrosis factor in the heart. Am J Physiol Regulatory Integrative Comp Physiol 274: R577-R595, 1998.
45. Meldrum DR, Shenkar R, Sheridan BC, Cain BS, Abraham E, and Harken AH. Hemorrhage activates myocardial NF-κB and increases tumor necrosis factor in the heart. J Mol Cell Cardiol 29: 2849-2854, 1997.
46. Olivera DL, Esser KM, Lee JC, Greig RG, and Badger AM. Beneficial effects of SK&F 105809, a novel cytokine-suppressive agent, in murine models of endotoxin shock. Circ Shock 37: 301-306, 1992.
47. Ono K and Han J. The p38 signal transduction pathway: Activation and function. Cell Signal 12: 1-13, 2000.
48. Oral H, Dorn GW, and Mann DL. Sphingosine mediates the immediate negative inotropic effects of tumor necrosis factor-α in the adult mammalian cardiac myocyte. J Biol Chem 272: 4836-4842, 1997.
49. Pietersma A, Tilly BC, Gaestel M, de Jong N, Lee JC, Koster JF, and Sluiter W. p38 Mitogen activated protein kinase regulates endothelial VCAM-1 expression at the post-transcriptional level. Biochem Biophys Res Commun 230: 44-48, 1997.
50. PAK, p38 mitogen-activated protein kinase (MAPK), and stress-activated protein kinase (SAPK) in cultured rat cardiac myocytes. Biochem Biophys Res Commun 239: 840-844, 1997.
51. She QB, Chen N, and Dong Z. ERKs and p38 kinase phosphorylate p53 protein at serine 14 in response to UV radiation. J Biol Chem 275: 20444-20449, 2000.
52. Sugden PH and Clerk A. "Stress-responsive" mitogen-activated protein kinases (c-Jun N-terminal kinases and p38 mitogen-activated protein kinases) in the myocardium. Circ Res 83: 345-352, 1998.
53. Swantek JL, Cobb MH, and Geppert TD. Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-α) translation: glycacorticoids inhibit TNF-α translation by blocking JNK/SAPK. Mol Cell Biol 17: 6274-6282, 1997.
54. Tokyay R, Zeigler ST, Traver DL, Stothert JC Jr, Loick HM, Heggers JP, and Herndon DN. Postburn gastrointestinal vasoconstriction increases bacterial and endotoxin translocation. J Appl Physiol 74: 1521-1527, 1993.
55. Wang Y, Huang S, Sah VP, Ross J, Brown JH, Han J, and Chien KR. Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family. J Biol Chem 273: 2161-2168, 1998.
56. Weinbrenner C, Liu GS, Cohen MV, and Downey JM. Phosphorylation of tyrosine 182 of p38 mitogen-activated protein kinase correlates with the protection of preconditioning in the rabbit heart. J Mol Cell Cardiol 29: 2383-2391, 1997.
57. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, and Mathison JC. CD 14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249: 1431-1433, 1990.
58. Yokoyama T, Vaca L, Rossen RD, Durante W, Hazarika P, and Mann DL. Cellular basis for the negative inotropic effects of tumor necrosis factor-α in the adult mammalian cardiac myocyte. J Clin Invest 92: 2303-2312, 1993.